Literature DB >> 7427627

Rifampicin-associated pseudomembranous colitis.

S P Boriello, R H Jones, I Phillips.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7427627      PMCID： PMC1714520          DOI： 10.1136/bmj.281.6249.1180-a

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  3 in total

1.  Pseudomembranous colitis probably due to rifampicin.

Authors:  G Fournier; J Orgiazzi; B Lenoir; M Dechavanne
Journal:  Lancet       Date:  1980-01-12       Impact factor: 79.321

2.  Pseudomembranous colitis and rifampicin.

Authors:  G Acocella; V Arioli
Journal:  Lancet       Date:  1980-04-12       Impact factor: 79.321

3.  Clostridium difficile and the aetiology of pseudomembranous colitis.

Authors:  H E Larson; A B Price; P Honour; S P Borriello
Journal:  Lancet       Date:  1978-05-20       Impact factor: 79.321
  3 in total
  3 in total

1.  Development of pseudomembranous colitis four months after initiation of rifampicin.

Authors:  Jeong Moon Choi; Hyung Hun Kim; Seun Ja Park; Moo In Park; Won Moon
Journal:  Case Rep Gastroenterol       Date:  2011-01-14

2.  A case of pseudomembranous colitis associated with rifampin.

Authors:  Ji Young Park; Joon Seok Kim; Sun Jong Jeung; Myung Sook Kim; Seok Chan Kim
Journal:  Korean J Intern Med       Date:  2004-12       Impact factor: 2.884

3.  Incidence and Clinical Outcomes of Clostridium difficile Infection after Treatment with Tuberculosis Medication.

Authors:  Yu Mi Lee; Kyu Chan Huh; Soon Man Yoon; Byung Ik Jang; Jeong Eun Shin; Hoon Sup Koo; Yunho Jung; Sae Hee Kim; Hee Seok Moon; Seung Woo Lee
Journal:  Gut Liver       Date:  2016-03       Impact factor: 4.519
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.